Nurix Therapeutics's total assets for Q4 2024 were $669.34M, an increase of 30.32% from the previous quarter. NRIX total liabilities were $142.35M for the fiscal quarter, a 4.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.